Clinical Characteristics of Hospitalized Patients With COVID-19 and Their Association With the Progression to Critical Illness and Death: A Single-Center Retrospective Study From Northwestern Mexico

被引:0
作者
Martinez-Villa, Francisco A. [1 ,2 ]
Angulo-Zamudio, Uriel A. [1 ]
Leon-Sicairos, Nidia [1 ,3 ]
Gonzalez-Esparza, Ricardo [1 ,2 ]
Sanchez-Cuen, Jaime [1 ,4 ]
Martinez-Garcia, Jesus J. [1 ,3 ]
Flores-Villasenor, Hector [1 ,5 ]
Medina-Serrano, Julio [6 ]
Canizalez-Roman, Adrian [1 ,7 ]
机构
[1] Autonomous Univ Sinaloa, Sch Med, Culiacan, Sinaloa, Mexico
[2] IMSS, Dept Med Gen, Unidad Med Familiar 21, La Cruz De Elota, Sinaloa, Mexico
[3] Pediat Hosp Sinaloa, Res Dept, Culiacan, Sinaloa, Mexico
[4] ISSSTE, Hosp Reg, Res Dept, Culiacan, Sinaloa, Mexico
[5] Secretariat Hlth, Mol Biol Dept, Sinaloa State Publ Hlth Lab, Culiacan, Sinaloa, Mexico
[6] Delegac IMSS, Res Dept, Coordinac Invest Salud, Culiacan, Sinaloa, Mexico
[7] Secretariat Hlth, Womens Hosp, Res Dept, Culiacan, Sinaloa, Mexico
关键词
COVID-19; critical illness; death; Mexico; SARS-CoV-2; ILL PATIENTS; MORTALITY; SEVERITY; PROFILES; WUHAN;
D O I
10.1111/crj.13813
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objective: The objective of this study was to associate the epidemiological and clinical characteristics of patients hospitalized for COVID-19 with the progression to critical illness and death in northwestern Mexico. Methods: From March to October 2020, we collected the demographic and clinical characteristics of 464 hospitalized patients from northwestern Mexico. Results: Sixty-four percent (295/464) of the patients became critically ill. Age, occupation, steroid and antibiotic use at previous hospitalization, and underlying diseases (hypertension, obesity, and chronic kidney disease) were associated with critical illness or death (p: < 0.05). No symptoms were associated with critical illness. However, the parameters such as the heart rate, respiratory rate, oxygen saturation, and diastolic pressure and the laboratory parameters such as the glucose, creatinine, white line cells, hemoglobin, D-dimer, and C-reactive protein, among others, were associated with critical illness (p: < 0.05). Finally, advanced age, previous hospital treatment, and the presence of one or more underlying diseases were associated with critical illness and death (p: < 0.02). Conclusions: Several epidemiological (e.g., age and occupation) and clinical factors (e.g., previous treatment, underlying diseases, and vital signs and laboratory parameters) were associated with critical illness and death in patients hospitalized with COVID-19. These data provide us with possible markers to avoid critical illness or death from COVID-19 in our region.
引用
收藏
页数:11
相关论文
共 55 条
  • [1] AlansNaranjo J. M., 2021, Microbes, Infection and Chemotherapy, V1
  • [2] COVID-19 in critically ill patients in North Brabant, the Netherlands: Patient characteristics and outcomes
    Aleva, F. E.
    van Mourik, L.
    Broeders, M. E. A. C.
    Paling, A. J.
    de Jager, C. P. C.
    [J]. JOURNAL OF CRITICAL CARE, 2020, 60 : 111 - 115
  • [3] Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study
    Alharthy, Abdulrahman
    Aletreby, Waleed
    Faqihi, Fahad
    Balhamar, Abdullah
    Alaklobi, Feisal
    Alanezi, Khaled
    Jaganathan, Parameaswari
    Tamim, Hani
    Alqahtani, Saleh A.
    Karakitsos, Dimitrios
    Memish, Ziad A.
    [J]. JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH, 2021, 11 (01) : 98 - 104
  • [4] [Anonymous], 2021, Epidemiolgicos IdDyR , Lineamientos Para la Vigilancia por Laboratorio de Virus Respiratorio
  • [5] Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State
    Arentz, Matt
    Yim, Eric
    Klaff, Lindy
    Lokhandwala, Sharukh
    Riedo, Francis X.
    Chong, Maria
    Lee, Melissa
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16): : 1612 - 1614
  • [6] Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy
    Bendala Estrada, Alejandro David
    Calderon Parra, Jorge
    Fernandez Carracedo, Eduardo
    Muino Miguez, Antonio
    Ramos Martinez, Antonio
    Munez Rubio, Elena
    Rubio-Rivas, Manuel
    Agudo, Paloma
    Arnalich Fernandez, Francisco
    Estrada Perez, Vicente
    Taboada Martinez, Maria Luisa
    Crestelo Vieitez, Anxela
    Pesqueira Fontan, Paula Maria
    Bustamante, Marta
    Freire, Santiago J.
    Oriol-Bermudez, Isabel
    Artero, Arturo
    Olalla Sierra, Julian
    Areses Manrique, Maria
    Javier Carrasco-Sanchez, H. Francisco
    Carolina Vento, Vanessa
    Garcia Garcia, Gema Maria
    Cubero-Morais, Pablo
    Casas-Rojo, Jose-Manuel
    Millan Nunez-Cortes, Jesus
    [J]. BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [7] Symptom Profiles of a Convenience Sample of Patients with COVID-19-United States, January-April 2020
    Burke, Rachel M.
    Killerby, Marie E.
    Newton, Suzanne
    Ashworth, Candace E.
    Berns, Abby L.
    Brennan, Skyler
    Bressler, Jonathan M.
    Bye, Erica
    Crawford, Richard
    Morano, Laurel Harduar
    Lewis, Nathaniel M.
    Markus, Tiffanie M.
    Read, Jennifer S.
    Rissman, Tamara
    Taylor, Joanne
    Tate, Jacqueline E.
    Midgley, Claire M.
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (28): : 904 - 908
  • [8] Antibiotic Use and Fatal Outcomes among Critically Ill Patients with COVID-19 in Tacna, Peru
    Copaja-Corzo, Cesar
    Hueda-Zavaleta, Miguel
    Benites-Zapata, Vicente A.
    Rodriguez-Morales, Alfonso J.
    [J]. ANTIBIOTICS-BASEL, 2021, 10 (08):
  • [9] Docherty A.B., 2020, medRxiv, DOI [10.1136/bmj.m1985, 10.1101/2020.04.23.20076042thisversion]
  • [10] Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status
    Du, Hui
    Dong, Xiang
    Zhang, Jin-jin
    Cao, Yi-yuan
    Akdis, Mubeccel
    Huang, Pei-qi
    Chen, Hong-wei
    Li, Ying
    Liu, Guang-hui
    Akdis, Cezmi A.
    Lu, Xiao-xia
    Gao, Ya-dong
    [J]. ALLERGY, 2021, 76 (02) : 510 - 532